{
    "clinical_study": {
        "@rank": "104261", 
        "arm_group": [
            {
                "arm_group_label": "bilevel ventilation BIPAP ST", 
                "arm_group_type": "Active Comparator", 
                "description": "one night, BIPAP ST ventilation with individually optimised pressure parameters and supplemental oxygen if necessary."
            }, 
            {
                "arm_group_label": "BIPAP ST plus Airtrap", 
                "arm_group_type": "Experimental", 
                "description": "one night, BIPAP ST ventilation with \"Airtrap control\", same pressure parameters and oxygen."
            }
        ], 
        "brief_summary": {
            "textblock": "15 COPD patients will be surveyed in this prospective randomized crossover pilot study\n      concerning non invasive ventilation. Patients will be treated over 2 nights in randomized\n      order with Ventimotion2 (Weinmann) with and without Airtrap Control under Polysomnography\n      (PSG) surveillance including transcutaneous pCO2 measurement. The sleep quality is judged by\n      evaluating the PSG and pCO2 values over night.\n\n      Target parameters are respiratory rate, sleep quality and influence of Airtrap Control on\n      pCO2 values over night."
        }, 
        "brief_title": "The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "COPD", 
            "Hypercapnic Respiratory Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypercapnia", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Hypoventilation", 
                "Respiratory Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stable respiratory situation\n\n          -  Clinically required NIV\n\n          -  Capable of giving consent\n\n        Exclusion Criteria:\n\n          -  Invasive ventilation\n\n          -  Any other severe physical disease that requires immediate medical assistance\n\n          -  Acute hypercapnic decompensation with pH <7.30 in routine BGA\n\n          -  Circumstances that doesn't allow mask ventilation (e.g. facial deformation)\n\n          -  Participation in a clinical trial within the last 4 weeks\n\n          -  Pregnancy or nursing period\n\n          -  Drug addiction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01987661", 
            "org_study_id": "Airtrap2013"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "bilevel ventilation BIPAP ST", 
                    "BIPAP ST plus Airtrap"
                ], 
                "description": "non invasive ventilation, individually titrated for each patient, if necessary combined with oxygen, to improve hypercapnic respiratory failure.", 
                "intervention_name": "BIPAP ST", 
                "intervention_type": "Device", 
                "other_name": "Ventimotion 2"
            }, 
            {
                "arm_group_label": "BIPAP ST plus Airtrap", 
                "description": "Addional to the individally titrated BiPAP ventilation parameters the function \"AirTrap Control\" is added.\nAirTrap Control helps to prevent dynamic hyperinflation and makes it possible for VENTImotion 2 to automatically regulate to the best frequency and expiration time.", 
                "intervention_name": "Airtrap", 
                "intervention_type": "Device", 
                "other_name": "Ventimotion 2, Weinmann"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "NIV", 
            "Airtrapping", 
            "Ventimotion2"
        ], 
        "lastchanged_date": "November 13, 2013", 
        "location": {
            "contact": {
                "email": "georg.nilius@helios-kliniken.de", 
                "last_name": "Georg Nilius, MD", 
                "phone": "0049 2331 974", 
                "phone_ext": "2000"
            }, 
            "facility": {
                "address": {
                    "city": "Hagen", 
                    "country": "Germany", 
                    "state": "NRW", 
                    "zip": "58091"
                }, 
                "name": "Helios Klinik Hagen"
            }, 
            "investigator": {
                "last_name": "Karl Heinz R\u00fchle, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "German: Einfluss Von Airtrapping Auf Atmung Und Schlaf Bei Nichtinvasiver Beatmung (NIV) Von COPD Patienten", 
        "other_outcome": {
            "description": "Sleep efficiency is defined by the relation of \"time in bed\" to \"total sleep time\" in the overnight polysomnography protocol", 
            "measure": "Sleep efficiency", 
            "safety_issue": "No", 
            "time_frame": "2 nights"
        }, 
        "overall_contact": {
            "email": "georg.nilius@helios-kliniken.de", 
            "last_name": "Georg Nilius, MD", 
            "phone": "0049 2331 974", 
            "phone_ext": "2000"
        }, 
        "overall_contact_backup": {
            "email": "ulrike.domanski@helios-kliniken.de", 
            "last_name": "Ulrike Domanski", 
            "phone": "0049 2331 974", 
            "phone_ext": "2080"
        }, 
        "overall_official": {
            "affiliation": "Helios Klinik Hagen", 
            "last_name": "Georg Nilius, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "breathing frequency measured with the flow signal of a polysomnography during non invasive ventilation over night", 
            "measure": "breathing frequency", 
            "safety_issue": "No", 
            "time_frame": "2 nights"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01987661"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Institut f\u00fcr Pneumologie Hagen Ambrock eV", 
            "investigator_full_name": "Karl Heinz Ruehle", 
            "investigator_title": "Head of Institut f\u00fcr Pneumologie hagen Ambrock eV", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "mean pCO2 level over night  measured with a transcutanous pCO2 monitor (TOSCA)", 
            "measure": "mean pCO2 level", 
            "safety_issue": "No", 
            "time_frame": "2 nights"
        }, 
        "source": "Institut f\u00fcr Pneumologie Hagen Ambrock eV", 
        "sponsors": {
            "collaborator": {
                "agency": "Weinmann Ger\u00e4te f\u00fcr Medizin GmbH + Co. KG", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Karl Heinz Ruehle", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}